Clinic
Fairview Clinics
Fairview Clinics was paid $5.03M by Medicaid between Oct 2020 and Dec 2024, across 118 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoFAIRVIEW CLINICS
SAINT PAUL, MN 55103
SAINT PAUL, MN 55103
33aNPI1306470737assigned 02/25/2020
33bProvider typeClinic/Center
28Total paid$5.03M
24GClaims131,831
24DCodes billed118
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Minnesota
Rank by total paid#12 of 250
Median peer was paid$274K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 8,251 | $244K | |
| 2021 | 39,796 | $1.37M | |
| 2022 | 33,862 | $1.27M | |
| 2023 | 26,760 | $1.13M | |
| 2024incomplete | 23,162 | $1.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 25,067 | 22,766 | $2.26M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 18,052 | 16,881 | $1.19M |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 5.6% | 4,798 | 4,694 | $279K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.5% | 12,055 | 11,687 | $174K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 1,385 | 1,295 | $104K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 17,656 | 16,468 | $93K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.6% | 4,181 | 4,052 | $80K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 674 | 671 | $56K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 590 | 587 | $50K |
| 90686 | <1% | 5,092 | 4,975 | $44K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 465 | 461 | $42K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,910 | 3,815 | $36K |
106 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,375 | $35K |
| 80061 | Lipid panel | <1% | 2,453 | $32K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 417 | $32K |
| 91320 | <1% | 373 | $30K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 559 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,383 | $20K |
| 90480 | <1% | 655 | $19K | |
| 86481 | <1% | 248 | $19K | |
| 92551 | <1% | 2,305 | $18K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 480 | $16K |
| 80053 | Comprehensive metabolic panel | <1% | 1,630 | $16K |
| 90715 | <1% | 820 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 374 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 714 | $15K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 108 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 403 | $14K |
| 0012A | <1% | 296 | $13K | |
| 0011A | <1% | 309 | $12K | |
| 85027 | <1% | 1,757 | $11K | |
| X5622 | <1% | 90 | $10K | |
| 90651 | <1% | 376 | $10K | |
| 99188 | <1% | 1,032 | $9K | |
| 90656 | <1% | 943 | $9K | |
| 96127 | <1% | 2,157 | $9K | |
| 90662 | <1% | 143 | $8K | |
| 0064A | <1% | 205 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 478 | $8K |
| 0002A | <1% | 288 | $8K | |
| 0054A | <1% | 167 | $7K | |
| 0001A | <1% | 300 | $7K | |
| 86780 | <1% | 580 | $7K | |
| 99000 | <1% | 636 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 67 | $7K |
| 86803 | <1% | 564 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 70 | $6K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 36 | $5K |
| 80306 | <1% | 299 | $5K | |
| 81025 | <1% | 586 | $5K | |
| 59425 | <1% | 12 | $5K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 126 | $5K |
| 90677 | <1% | 45 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 41 | $5K |
| 0072A | <1% | 112 | $5K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 197 | $5K |
| 0071A | <1% | 109 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 117 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 549 | $4K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 86 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 42 | $4K |
| 87210 | <1% | 608 | $4K | |
| 87340 | <1% | 437 | $3K | |
| 99173 | <1% | 2,142 | $3K | |
| 0004A | <1% | 76 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 390 | $3K |
| 0031A | <1% | 119 | $3K | |
| 90670 | <1% | 422 | $3K | |
| 86706 | <1% | 364 | $3K | |
| 86704 | <1% | 275 | $2K | |
| 0052A | <1% | 47 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 235 | $2K |
| 90691 | <1% | 15 | $2K | |
| 86708 | <1% | 228 | $2K | |
| 86787 | <1% | 203 | $2K | |
| 99385 | <1% | 15 | $2K | |
| 81001 | <1% | 465 | $2K | |
| 99442 | <1% | 35 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 133 | $1K |
| 83655 | <1% | 107 | $1K | |
| 82043 | <1% | 226 | $1K | |
| 99443 | <1% | 14 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 12 | $1K |
| 85018 | <1% | 402 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 84 | $1K |
| 0124A | <1% | 27 | $975.29 | |
| 99383 | <1% | 12 | $928.50 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30 | $904.79 |
| 90734 | <1% | 257 | $821.66 | |
| 96161 | <1% | 383 | $711.92 | |
| 90473 | <1% | 41 | $618.56 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 233 | $614.56 |
| 0051A | <1% | 14 | $606.90 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 27 | $564.58 |
| 81003 | <1% | 298 | $536.67 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $444.96 |
| 87338 | <1% | 27 | $416.04 | |
| 90716 | <1% | 12 | $341.36 | |
| 36416 | <1% | 72 | $212.39 | |
| 93000 | <1% | 18 | $173.09 | |
| 86709 | <1% | 13 | $146.25 | |
| 84439 | <1% | 12 | $113.74 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 255 | $109.70 |
| 90707 | <1% | 27 | $83.69 | |
| 82950 | <1% | 13 | $62.04 | |
| 82570 | <1% | 12 | $0.12 | |
| 90698 | 0% | 251 | $0.00 | |
| 90680 | 0% | 100 | $0.00 | |
| 90696 | 0% | 25 | $0.00 | |
| 90744 | 0% | 133 | $0.00 | |
| 90619 | 0% | 12 | $0.00 | |
| 90723 | 0% | 48 | $0.00 | |
| 90633 | 0% | 222 | $0.00 | |
| 90713 | 0% | 31 | $0.00 | |
| 90710 | 0% | 28 | $0.00 | |
| 90648 | 0% | 60 | $0.00 | |
| 86682 | 0% | 21 | $0.00 | |
| 90681 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.